Polyoxyethylene Impurity Analysis Using Far-UV HPLC Detection

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing methods are inadequate for highly sensitive analysis of the compound of formula (1) in polyoxyethylene derivatives, which is produced as an impurity during synthesis and can cause impurities in pharmaceutical products.

Innovation Solution

A method involving reversed-phase liquid chromatography with an ultraviolet visible spectrometer detector, using specific additives and conditions to analyze the compound of formula (1) in polyoxyethylene derivatives, including a detection wavelength of less than 200 nm and acidic substances in the mobile phase.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional liquid chromatography methods are used to analyze the compound of formula (1), then the analysis can be performed with standard equipment, but the detection sensitivity is insufficient to detect the compound at extremely low concentrations (100-1000 ppm level)

Engineering Contradiction:

Improvedetection sensitivityVSAvoiddifficulty of detecting compound at trace levels

Core Design Contradiction:

Measurement precisionVSDifficulty of detecting and measuring

Solution Approach 1:

The patent changes the detection wavelength parameter to ultraviolet light shorter than 200 nm, where the compound of formula (1) exhibits significantly higher absorption. This parameter change enables detection at extremely low concentrations (100-1000 ppm) that are invisible at conventional wavelengths (200-400 nm), directly resolving the sensitivity issue

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent introduces an acidic substance as an intermediary in the mobile phase to suppress ionization of the compound of formula (1). This intermediary prevents the compound from existing in ionized forms that would have low UV absorption, thereby enhancing detection sensitivity at trace levels without requiring complex sample preparation

Inventive Principle:

Principle #24Intermediary (Mediator)

2Measurement precision

If the detection wavelength is set to conventional ranges (200-400 nm), then the analysis is simpler and equipment is more accessible, but the compound of formula (1) cannot be detected at its actual trace concentrations

Engineering Contradiction:

Improvedetection limitVSAvoidease of implementing analysis method

Core Design Contradiction:

Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent shifts the detection wavelength to the far ultraviolet region (shorter than 200 nm), where the compound of formula (1) has strong absorption characteristics. This parameter change achieves detection limits suitable for trace analysis while remaining implementable with standard HPLC equipment equipped with UV detectors capable of far-UV operation

Inventive Principle:

Principle #35Parameter changes

3Reliability

If polyoxyethylene derivatives are used to modify biologically related substances, then the half-life and solubility are improved, but impurities including the compound of formula (1) are generated that can cause harmful effects

Engineering Contradiction:

Improvepharmaceutical product qualityVSAvoidimpurity generation

Core Design Contradiction:

ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent performs preliminary analysis of the polyoxyethylene derivative before it is used to modify biologically related substances. By detecting the compound of formula (1) at trace levels using the improved HPLC method, manufacturers can identify batches with excessive impurities and reject them before modification, preventing the generation of harmful impurities in the final pharmaceutical product

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent establishes a feedback mechanism through highly sensitive analysis that monitors the compound of formula (1) content in polyoxyethylene derivatives. This feedback enables quality control decisions to be made based on quantitative data, allowing manufacturers to adjust synthesis conditions or purification steps to minimize impurity generation while maintaining the beneficial effects of polyoxyethylene modification

Inventive Principle:

Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables highly sensitive detection of the compound of formula (1), improving quality control of pharmaceutical products by minimizing impurity production.

Implementation Method 1

detecting the compound with an ultraviolet visible spectrometer detector, wherein ultraviolet light with a wavelength shorter than 200 nm as the detection wavelength is used

Methodology Applied

Scientific EffectAbsorption Spectroscopy: Absorption Spectroscopy

Implementation Method 2

analyzing by reversed-phase liquid chromatography a polyoxyethylene derivative

Methodology Applied

Scientific EffectChromatography: Chromatography

Data Source

PatentEP4371662B1Method for analyzing reactive low-molecular-weight compound contained in polyoxyethylene derivative

Publication Date: 2025.12.31 NOF CORP

AI summary

The present invention provides an analysis method including separating a compound of the formula (1): contained in a polyoxyethylene derivative by reversed-phase chromatography, and detecting the compound with an ultraviolet visible spectrometer detector, in which ultraviolet light with a wavelength shorter than 200 nm as the detection wavelength is used, and an acidic substance with a maximum molar absorption coefficient of not more than 20 M-1cm-1 at 190 to 200 nm and a pKa of not more than 4 is used as an additive to the mobile phase for analysis.